Lunai Bioworks (LNAI) Total Non-Current Liabilities (2012 - 2026)

Lunai Bioworks (LNAI) recorded quarterly Total Non-Current Liabilities of $131316.0 in Q1 2026, down 38.54% quarter-over-quarter from $213657.0 in Q4 2025, and down 73.61% on a YoY basis from $497629.0 in Q1 2025.

Lunai Bioworks (LNAI) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Lunai Bioworks' Total Non-Current Liabilities history runs 11 years deep, the most recent figure standing at $131316.0 for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities fell 73.61% year-over-year to $131316.0; the TTM figure through Mar 2026 stood at $131316.0 (down 73.61% YoY), while the FY2025 annual figure was $424547.0, down 49.6% from the prior year.
  • Total Non-Current Liabilities was $131316.0 for Q1 2026 at Lunai Bioworks, down from $213657.0 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $22.8 million in Q1 2024 to a low of $131316.0 in Q1 2026.
  • Historically, Total Non-Current Liabilities has averaged $3.0 million across 5 years, with a median of $720801.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities surged 2650.77% in 2024, then slumped 97.82% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $2.1 million in 2022, then plunged by 68.1% to $664218.0 in 2023, then advanced by 1.5% to $674200.0 in 2024, then tumbled by 68.31% to $213657.0 in 2025, then sank by 38.54% to $131316.0 in 2026.
  • The last three Total Non-Current Liabilities figures came in at $131316.0 (Q1 2026), $213657.0 (Q4 2025), and $278963.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Lunai Bioworks 95.85 Mn 92.70 Mn 20,942.00 131,316.00

Historic Data

Download Data
DateValue
Mar 31, 2026 131,316.00
Dec 31, 2025 213,657.00
Sep 30, 2025 278,963.00
Jun 30, 2025 424,547.00
Mar 31, 2025 497,629.00
Dec 31, 2024 674,200.00
Sep 30, 2024 710,260.00
Jun 30, 2024 842,389.00
Mar 31, 2024 22.81 Mn
Dec 31, 2023 664,218.00
Sep 30, 2023 720,801.00
Jun 30, 2023 775,587.00
Mar 31, 2023 829,213.00
Dec 31, 2022 2.08 Mn
Sep 30, 2022 5.59 Mn
Jun 30, 2022 5.56 Mn
Mar 31, 2022 8.55 Mn
Dec 31, 2021 8.49 Mn
Sep 30, 2021 17.09 Mn
Jun 30, 2021 13.06 Mn